Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Acrux ( (AU:ACR) ).
Acrux Limited has announced the appointment of John Warmbrunn as the new CEO and Managing Director, effective June 1, 2025, following the retirement of Michael Kotsanis. Warmbrunn brings over 25 years of experience in the healthcare sector, with a strong track record in international business growth and leadership roles at companies like Ego Pharmaceuticals and Bendigo Community Telco. His appointment is expected to drive Acrux’s next phase of growth, particularly in expanding its international market presence.
More about Acrux
Acrux Limited operates in the pharmaceutical industry, focusing on developing and marketing topical generic pharmaceutical products. The company is expanding its range of marketed products internationally, aiming to leverage its expertise in bringing products to market.
Average Trading Volume: 244,310
Technical Sentiment Signal: Sell
Current Market Cap: A$9.37M
See more insights into ACR stock on TipRanks’ Stock Analysis page.